Another case identified an EML4::ALK rearrangement in LCNEC with crizotinib resistance [5], suggesting that perhaps ALK-positive LCNEC is derived from ALK-positive ACA via tumor plasticity. The gene discussed is ALK; the disease is neoplasm.